This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Kurth AA, Kotowa W, Fricke FU, Quednau K, Maiwenn JA.Zoledronic acid in the long-term management of Paget's disease of the bone in Germany - a cost-saving approach? Value in Health 9: A220 (plus poster) abstr. PAR2, No. 6, Nov-Dec 2006
Kosa J.An economic evaluation of zoledronic acid treatment in Paget's disease of bone in the Hungarian health care setting. Value in Health 9: A380, No. 6, Nov-Dec 2006
Rights and permissions
About this article
Cite this article
Zoledronic acid dominant option for Paget's disease in Germany, Hungary. Pharmacoecon. Outcomes News 517, 1 (2006). https://doi.org/10.2165/00151234-200605170-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605170-00001